Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Size: px
Start display at page:

Download "Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects"

Transcription

1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p Vol. 40, No /96/$ Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects YAN-QIONG XIONG, JOCELYNE CAILLON, HENRI DRUGEON, GILLES POTEL,* AND DENIS BARON Laboratoire d Antibiologie Clinique et Expérimentale, Faculté demédecine, Centre Hospitalier Universitaire, Nantes, France Received 12 June 1995/Returned for modification 30 August 1995/Accepted 27 October 1995 Adaptive resistance to aminoglycosides in Pseudomonas aeruginosa and other gram-negative bacilli is usually induced by the initial exposure to the drug. We investigated the influence of ph on the adaptive resistance of a clinical P. aeruginosa strain to aminoglycosides in vitro and on their postantibiotic effects. For adaptive resistance, the first-exposure concentrations of both amikacin and netilmicin were one, two, four, and eight times the MIC of each drug and the second-exposure concentrations were two times the MIC of each drug. Adaptive resistance was greater and more prolonged with higher initial aminoglycoside concentrations, and the bactericidal effects of the aminoglycosides were concentration dependent at ph 7.4. At ph 6.5, the killing rates of amikacin and netilmicin were far lower than those observed at ph 7.4. At ph 5.5, amikacin and netilmicin exerted practically no bactericidal effect on the P. aeruginosa strain used. However, with media at ph 5.5 and 6.5, adaptive resistance of P. aeruginosa preexposed to amikacin and netilmicin was also clearly exhibited, with the degree of adaptive resistance depending on the bactericidal effects of both drugs on nonpreexposed controls. Maximal adaptive resistance occurred between 0 and 4 h after preexposure. The postantibiotic effects of amikacin and netilmicin against the P. aeruginosa strain were shown to be concentration dependent and were reduced at acidic phs. No changes in outer and inner membrane proteins occurred during the adaptiveresistance interval. Adaptive resistance for Pseudomonas aeruginosa and other gram-negative bacilli after exposure to aminoglycosides has been recently described. This reversible form of resistance develops within 2 to 3 h of the initial exposure to an aminoglycoside and then disappears during growth for several hours in a drug-free medium (2, 5, 6). The mechanism of adaptive resistance is not completely understood but is probably related to the reversible downregulation of aminoglycoside uptake during the period of accelerated energy-dependent drug transport (5) and to the decreased proton motive force during the adaptive-resistance interval (reduced killing) (14). Aminoglycosides need to cross the bacterial cytoplasmic membrane before initiating lethal effects. It is well known that increased aminoglycoside uptake is associated with an enhanced bactericidal effect. Previous data have demonstrated that aminoglycoside transport is regulated by, the electrical component of the proton motive force; more specifically, uptake is dependent on (3, 9, 10, 16). Eisenberg et al. indicated that there is generally an increase in the magnitude of at the expense of ph (the transmembrane difference in the H concentration) (9). Moreover, acidic phs seem to have a deleterious effect on aminoglycoside bactericidal activity, although only a few studies have investigated this aspect (12). The purpose of this study was to determine the influence of ph (7.4, 6.5, and 5.5) on the adaptive resistance of P. aeruginosa to amikacin and netilmicin and on the postantibiotic effects (PAEs) of amikacin and netilmicin on P. aeruginosa in vitro as well as to monitor changes in outer and inner membrane proteins during the adaptive-resistance interval. * Corresponding author. Mailing address: Laboratoire d Antibiologie, Faculté de Médecine, Nantes, France. Phone: (33) Fax: (33) MATERIALS AND METHODS Organism. The P. aeruginosa strain studied was isolated from respiratory secretions and proved susceptible to -lactams, quinolones, and aminoglycosides. Antibiotics. Amikacin and netilmicin, supplied by Bristol Laboratories (Paris, France) and Schering-Plough Laboratories (Levallois-Perret, France), respectively, were dissolved in sterile water. Susceptibility testing. MICs were determined by macrodilution in Mueller- Hinton broth supplemented with Ca 2 and Mg 2 (1), with a final bacterial inoculum of 10 5 to 10 6 CFU/ml. MICs and minimum bactericidal concentrations were defined as the lowest concentrations completely inhibiting growth and killing 99.9% of the inoculum, respectively. PAE. The PAE was assessed by the repeated-washing method, as previously described (4). Cultures were incubated at 37 C in various concentrations of amikacin or netilmicin at different phs (ph 7.4, 6.5, and 5.5) for 1 h prior to removal of the antibiotic by two washes (8,000 g for 10 min) and resuspension of the bacterial pellet in fresh drug-free medium. The PAE was then assessed, and the following equation was formulated for quantitation of the PAE: PAE T C, where T is the time required for the CFU count in the test culture to increase 1 log 10 (10-fold) above that observed immediately after drug removal and C is the time required for the CFU count in an untreated control culture to increase by 1 log 10 above that observed immediately after completion of the same procedure used on the test culture after drug removal. Adaptive resistance in vitro. Adaptive resistance was induced as previously described (5). An overnight culture was diluted 10-fold in Mueller-Hinton broth and incubated with different concentrations of amikacin or netilmicin for 1 h at 37 C. An identical sample of the same culture was simultaneously incubated in drug-free broth and used as a control. After 1 h, bacteria were harvested by centrifugation at 8,000 g for 10 min and washed twice with drug-free medium. The pellet was resuspended and diluted in drug-free broth to yield a suspension of viable postexposure CFU/ml and was incubated at 37 C. Aliquots of the cultures were removed hourly for 7 h and reexposed to two times the MIC (2MIC) of amikacin or netilmicin. Colony counts were determined before and after exposure, and the difference was expressed as bacterial killing after 90 min. The bacterial killing values for the culture with prior exposure to amikacin or netilmicin were compared with those for the control culture with no prior exposure to antibiotics. Adaptive resistance was observed when the bactericidal effect was less than that noted at the same time point in the control experiment. Outer and inner membrane proteins. Whole-cell preparations and cellular subfractions were isolated as previously described (18). An overnight culture was diluted 10-fold in Mueller-Hinton broth (T 1 ) and incubated with 8MIC of amikacin or netilmicin for 1 h (until T 0 )at37 C. An identical sample of the same culture was simultaneously incubated in drug-free broth and used as a control. After 1 h, bacteria were harvested by centrifugation at 8,000 g for 10 min and 35

2 36 XIONG ET AL. ANTIMICROB. AGENTS CHEMOTHER. FIG. 1. Antibacterial effects of first and second exposures to amikacin (AMK) against P. aeruginosa in medium at ph 7.4. (A) Bactericidal effect of first amikacin exposure on control culture. (B to E) Bactericidal effects of second amikacin exposure on test cultures. For these panels, the first exposures were MIC, 2MIC, 4MIC, and 8MIC of amikacin, respectively. FIG. 2. Antibacterial effects of first and second exposures to netilmicin (NET) against P. aeruginosa in medium at ph 7.4. (A) Bactericidal effect of first netilmicin exposure on control culture. (B to E) Bactericidal effects of second netilmicin exposures on test cultures. For these pan first exposure is MIC, 2MIC, 4MIC, and 8MIC of netilmicin, respectively.

3 VOL. 40, 1996 INFLUENCE OF ph ON ADAPTIVE RESISTANCE 37 Downloaded from FIG. 3. Antibacterial effects of first and second exposures to amikacin (AMK) against P. aeruginosa in media at different phs. (A to C) Bactericidal effects of first amikacin (2MIC) exposure on control cultures at ph 7.4, 6.5, and 5.5, respectively. (D to F) Bactericidal effects of a second amikacin (2MIC) exposure on test cultures at ph 7.4, 6.5, and 5.5, respectively. The first exposure was to 8MIC of amikacin. washed twice with drug-free medium. The pellet was resuspended and diluted in drug-free broth and incubated at 37 C for7h.att 1,T 0,T 2, and T 7, cells of the control, amikacin, and netilmicin groups were harvested by centrifugation at 8,000 g for 10 min at 4 C (A 600, 0.4 to 0.5). The cells were disrupted by sonication. The differentiation of outer and inner membrane proteins was based on the differential solubilities of these proteins in Sarkosyl. The reaction was stopped with 20% Sarkosyl, and the samples were prepared for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (13). RESULTS PAE. The PAEs of amikacin and netilmicin against P. aeruginosa were shown to be concentration dependent and were reduced at acidic phs (Table 1). At ph 7.4, the PAE of amikacin and netilmicin after exposure to 8MIC of each drug was about 1 h. With lower concentrations, the duration of the PAE was reduced. At ph 6.5, the PAEs of amikacin and netilmicin were shorter than at ph 7.4. At ph 5.5, amikacin exhibited practically no PAE at 4MIC, and netilmicin had only a 0.6-h PAE at 4MIC. Adaptive resistance. The results of adaptive resistance to amikacin and netilmicin (with different concentrations of these compounds after 1 h of preexposure) in the P. aeruginosa strain in ph 7.4 medium are shown in Fig. 1 and 2, respectively. on January 14, 2019 by guest TABLE 1. PAEs for various concentrations of amikacin and netilmicin at different phs a ph MIC/MBC (mg/liter) AMK PAE (h) for drug at concn (mg/liter) NET AMK NET /4 4/ /4 4/8 ND ND ND ND /8 8/16 ND ND ND ND a Abbreviations: MBC, minimum bactericidal concentration; AMK, amikacin; NET, netilmicin; ND, not determined.

4 38 XIONG ET AL. ANTIMICROB. AGENTS CHEMOTHER. Downloaded from FIG. 4. Antibacterial effects of first and second exposures to netilmicin (NET) against P. aeruginosa in media at different phs. (A to C) Bactericidal effects of first netilmicin (2MIC) exposure on control cultures at ph 7.4, 6.5, and 5.5, respectively. (D to F) Bactericidal effects of a second netilmicin (2MIC) exposure on test cultures at ph 7.4, 6.5, and 5.5, respectively. The first exposure was to 8MIC of netilmicin. Figure 1 shows that the addition of 2MIC of amikacin (final concentration, 4 mg/liter) in the control culture (without 1-h preexposure) produced bacterial killing of 1.3 to 2.3 log CFU/ ml/90 min at each hourly interval for 7 h (Fig. 1A). The test culture (with 1-h preexposure to 4MIC or 8MIC of amikacin) showed the development and subsequent decline of unstable adaptive resistance when amikacin (4 mg/liter) was added during 7-h growth periods in drug-free medium (Fig. 1D and E). However, with 1-h preexposure to the MIC and 2MIC of amikacin, adaptive resistance was not clearly exhibited (Fig. 1B and C). Figure 2, representing the netilmicin control (Fig. 2A), shows that the addition of 2MIC of netilmicin (final concentration, 8 mg/liter) produced bacterial killing of 1.5 to 2.3 log CFU/ml/90 min at each hourly interval for 7 h. The test culture (Fig. 2B to 2E) clearly showed unstable adaptive resistance to the readdition of netilmicin (8 mg/liter), even with 1-h preexposure to the MIC. The effects of ph (7.4, 6.5, and 5.5) on the adaptive resistance of P. aeruginosa to amikacin and netilmicin are shown in Fig. 3 and 4, respectively. At ph 6.5, the bacterial killing by amikacin (Fig. 3B) was far lower than that at ph 7.4 (Fig. 3A) but was less so for netilmicin (Fig. 4B vs. 4A). At ph 5.5, amikacin and netilmicin had practically no bactericidal effect on the P. aeruginosa strain (Fig. 3C and 4C). For the test group (8MIC of amikacin or netilmicin for 1 h ofpreexposure), the degree and duration of adaptive resistance at ph 6.5 and 5.5 depended on the bactericidal effect of the control, although adaptive resistance was still clearly exhibited. The duration of adaptive resistance was similar with media at different phs (about 3 to 4 h for amikacin and 5 h for netilmicin [Fig. 3D to F and 4D to F]), whereas the intensity was more marked at ph 6.5 than at ph 7.4. After initial drug exposure, the degree of adaptive resistance was very marked at 2 h for amikacin and from 2 to 4 h for netilmicin. Outer and inner membrane proteins. No changes in outer and inner membrane proteins occurred during the adaptiveresistance interval (data not shown). DISCUSSION Few studies have investigated the influence of ph on adaptive resistance of P. aeruginosa to aminoglycosides. As is well known, the bactericidal effect of the aminoglycosides is relative to the ph of the medium (7, 8). In our experiments at ph 5.5, amikacin and netilmicin had practically no bactericidal effect on P. aeruginosa. At ph 6.5, the killing by amikacin and netilmicin was far lower than that at ph 7.4. This resistance phe- on January 14, 2019 by guest

5 VOL. 40, 1996 INFLUENCE OF ph ON ADAPTIVE RESISTANCE 39 nomenon in media at acidic phs may have been due to a failure of drug uptake. In order to reach their ribosomal intracellular targets, aminoglycosides must traverse the cytoplasmic membranes of bacteria. This process of aminoglycoside uptake contains three energy-dependent phases (EDP). The first phase is binding to the cell surface by ionic interactions. The second phase (EDP-I) requires metabolic energy from the electron transport system that establishes a proton gradient between the inside and outside of the cytoplasmic membrane and is dependent on many factors (e.g., the ph of the medium). The final stage (EDP-II) involves the binding of the drug to ribosomes and necessitates active protein synthesis (8, 17). This final stage could be different from one aminoglycoside to another, possibly explaining some differences in killing rates. Some studies (9, 10, 15) demonstrated that increased aminoglycoside uptake is clearly associated with an enhanced bactericidal effect. Moreover, aminoglycoside uptake is dependent on, the electrical component of the proton motive force. Both aminoglycoside uptake and the subsequent lethal effect are proportional to the magnitude of. However, the magnitude of generally increases as the ph (transmembrane difference in the H concentration) decreases. Over the external ph range from 5.0 to 7.5, both and aminoglycoside uptake increased. Aminoglycoside uptake did not occur at ph 5.0 but was demonstrated at about ph 6.0. Thus, aminoglycoside uptake was clearly dependent on the magnitude of (9, 10, 15). The mechanism of adaptive resistance, although not clearly understood, could be related to reversible aminoglycoside-induced downregulation of drug uptake by bacteria, especially during the period of accelerated energy-dependent drug transport (4), and to a decrease in the magnitude of the electrical potential ( ) during the adaptive-resistance interval (14). We found no changes in outer and inner membrane proteins during the adaptive-resistance interval. The precise mechanisms of the PAE are unknown. Gottfredsson et al. (11) have demonstrated that DNA synthesis, as measured by thymidine uptake, decreases during the PAE and starts to recover about 20 to 40 min prior to growth by viable counts. We have shown that the PAEs of amikacin and netilmicin against the P. aeruginosa strain were reduced at acidic phs. Thus, the mechanism of PAE might be related to ph and. As demonstrated in other studies (2, 5, 6), adaptive resistance is an unstable, reversible form of resistance which develops within 1 to 3 h after initial exposure to an aminoglycoside and disappears several hours after its removal. Our experiments confirm the results of Barclay et al. (2), who used a dynamic model in vitro. They showed that higher initial aminoglycoside concentrations produce greater levels of bactericidal activity and more marked adaptive resistance at ph 7.4. Moreover, we found that adaptive resistance was obtained at lower preexposure concentrations of netilmicin than of amikacin. We evaluated the effects of ph (7.4, 6.5, and 5.5) on the adaptive resistance of P. aeruginosa to aminoglycosides. At ph 6.5 and 5.5, the degree and duration of adaptive resistance depended on the bactericidal effect of the control, although adaptive resistance was still clearly exhibited from 1 to 4 h after the first drug exposure. The durations of adaptive resistance were similar at different phs but seemed related to the antibiotic used (4 h for amikacin, 5 h for netilmicin). The intensity of adaptive resistance was greater at ph 6.5 than 7.4, but it is difficult to relate this result to an increase of the adaptiveresistance phenomenon because at acidic phs the bactericidal activity of the aminoglycosides was decreased. These results suggest that in clinical settings, when the ph of the infectious focus is under 7.4, the in vivo aminoglycoside concentration capable of inducing a bactericidal effect might be far above the MIC. REFERENCES 1. Amsterdam, D Susceptibility testing of antimicrobials in liquid media, p In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London. 2. Barclay, M. L., E. J. Begg, and S. T. Chambers Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob. Agents Chemother. 36: Bryan, L. E., and S. Kwan Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23: Craig, W. A., and S. Gudmundsson Postantibiotic effect, p In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London. 5. Daikos, G. L., G. G. Jackson, V. T. Lolans, and D. M. Livermore Adaptive resistance to aminoglycoside antibiotics from first-exposure downregulation. J. Infect. Dis. 162: Daikos, G. L., V. T. Lolans, and G. G. Jackson First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35: Damper, P. D., and W. Epstein Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob. Agents Chemother. 20: Davies, J. E Aminoglycoside-aminocyclitol antibiotics and their modifying enzymes, p In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London. 9. Eisenberg, E. S., L. J. Mandel, H. R. Kaback, and M. H. Miller Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J. Bacteriol. 157: Fraimow, H. S., J. B. Greenman, I. M. Leviton, T. J. Dougherty, and M. H. Miller Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP. J. Bacteriol. 173: Gottfredsson, M., H. Erlendsdottir, A. Gudmundsson, and S. Gudmundsson DNA synthesis in S. aureus and E. coli during the postantibiotic effect (PAE) phase, abstr. 935, p In Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 12. Gudmundsson, A., H. Erlendsdottir, M. Gottfredsson, and S. Gudmundsson The impact of ph and cationic supplementation on the postantibiotic effect (PAE) in vitro, abstr. 936, p In Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 13. Hancock, R. E. W., and A. M. Carey Outer membrane of Pseudomonas aeruginosa: heat- and 2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140: Karlowsky, J. A., G. G. Zhanel, R. J. Davidson, and D. J. Hoban Aminoglycoside induced adaptive resistance in Pseudomonas aeruginosa correlates with changes in membrane potential and can be eliminated by a H -ATPase inhibitor, abstr. C29, p. 74. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 15. Leviton, I. M., H. S. Fraimow, N. Carrasco, T. J. Dougherty, and M. H. Miller Tobramycin uptake in Escherichia coli membrane vesicles. Antimicrob. Agents Chemother. 39: Mates, S. M., E. S. Eisenberg, L. J. Mandel, L. Patel, H. R. Kaback, and M. H. Miller Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 79: Taber, H., W. J. P. Mueller, P. F. Miller, and A. S. Arrow Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51: Tuomanen, E., and J. Schwartz Penicillin-binding protein 7 and its relationship to lysis of nongrowing Escherichia coli. J. Bacteriol. 169:

Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method

Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method Journal of Antimicrobial Chemotherapy (1988) 22, 23-33 Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method Barforo Isaksson'*, Lennart Nibson*, Rolf Mailer' and

More information

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

More information

Introduction to Pharmacokinetics and Pharmacodynamics

Introduction to Pharmacokinetics and Pharmacodynamics Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:

More information

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,

More information

Advance Access published September 16, 2004

Advance Access published September 16, 2004 Advance Access published September 16, 2004 Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh435 JAC Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

Determination of antibiotic sensitivities by the

Determination of antibiotic sensitivities by the Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,

More information

Antibiotic Resistance in Bacteria

Antibiotic Resistance in Bacteria Antibiotic Resistance in Bacteria Electron Micrograph of E. Coli Diseases Caused by Bacteria 1928 1 2 Fleming 3 discovers penicillin the first antibiotic. Some Clinically Important Antibiotics Antibiotic

More information

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious

More information

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

WHY IS THIS IMPORTANT?

WHY IS THIS IMPORTANT? CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change

More information

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007 GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED

More information

Received 17 December 2003; accepted 22 December 2003

Received 17 December 2003; accepted 22 December 2003 Journal of Antimicrobial Chemotherapy (2004) 53, 609 615 DOI: 10.1093/jac/dkh130 Advance Access publication 3 March 2004 In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines,

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase

ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase Journal of Antimicrobial Chemotherapy (1996) 37, 881-889 ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase E. Culebras**, J. L.

More information

Antibiotic Susceptibility of Pseudomonas aeruginosa

Antibiotic Susceptibility of Pseudomonas aeruginosa ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1978, p. 979-984 0066-4804/78/0013-0979$02.00/0 Copyright ) 1978 American Society for Microbiology Vol. 13, No. 6 Printed in U.S.A. Effect of Triethylenetetramine

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Protein Synthesis Inhibitors

Protein Synthesis Inhibitors Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors

More information

Antibiotics & Resistance

Antibiotics & Resistance What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed

More information

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory ANTimICROBIAL AGENTh AND CHEMOTHERAPY, OCt. 1976, p. 677-681 Copyright 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae

More information

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

Boosting Bacterial Metabolism to Combat Antibiotic Resistance

Boosting Bacterial Metabolism to Combat Antibiotic Resistance Boosting Bacterial Metabolism to Combat Antibiotic Resistance The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

Alasdair P. MacGowan,* Chris A. Rogers, H. Alan Holt, and Karen E. Bowker

Alasdair P. MacGowan,* Chris A. Rogers, H. Alan Holt, and Karen E. Bowker ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2003, p. 1088 1095 Vol. 47, No. 3 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.3.1088 1095.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin

More information

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria

More information

Journal of Antimicrobial Chemotherapy Advance Access published August 26, 2006

Journal of Antimicrobial Chemotherapy Advance Access published August 26, 2006 Journal of Antimicrobial Chemotherapy Advance Access published August, Journal of Antimicrobial Chemotherapy doi:./jac/dkl Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae,

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

Pharmacological Evaluation of Amikacin in Neonates

Pharmacological Evaluation of Amikacin in Neonates ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.

More information

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus TEST REPORT TEST TYPE: Liquid Suspension Time Kill Study -Quantitative Test Based On ASTM 2315 TEST METHOD of Colloidal Silver Product at Contact time points: 30 sec, 1 min, 2 min, 5 min, 10 min, 15 min

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Identification of Factors Affecting In Vivo Aminoglycoside Activity

Identification of Factors Affecting In Vivo Aminoglycoside Activity ANTiMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1992, p. 744-750 0066-4804/92/040744-07$02.00/0 Copyright 1992, American Society for Microbiology Vol. 36, No. 4 Identification of Factors Affecting In Vivo

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017 Cell Wall Inhibitors Assistant Professor Naza M. Ali Lec 3 7 Nov 2017 Cell wall The cell wall is a rigid outer layer, it completely surrounds the cytoplasmic membrane, maintaining the shape of the cell

More information

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,

More information

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia

More information

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry

More information

Aminoglycoside-resistant enterococci

Aminoglycoside-resistant enterococci Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY

More information

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3)

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTIPRIO safely and effectively. See full prescribing information for OTIPRIO. OTIPRIO (ciprofloxacin

More information

Alasdair P. MacGowan*, Mandy Wootton and H. Alan Holt

Alasdair P. MacGowan*, Mandy Wootton and H. Alan Holt Journal of Antimicrobial Chemotherapy (1999) 43, 345 349 JAC The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial

More information

Antimicrobial agents

Antimicrobial agents Bacteriology Antimicrobial agents Learning Outcomes: At the end of this lecture, the students should be able to: Identify mechanisms of action of antimicrobial Drugs Know and understand key concepts about

More information

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length

More information

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Antimicrobial Resistance

Antimicrobial Resistance Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length

More information

Antimicrobial Resistance Acquisition of Foreign DNA

Antimicrobial Resistance Acquisition of Foreign DNA Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Antimicrobial Pharmacodynamics

Antimicrobial Pharmacodynamics Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they

More information

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin

More information

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities International Journal of Microbiology and Allied Sciences (IJOMAS) ISSN: 2382-5537 May 2016, 2(4):22-26 IJOMAS, 2016 Research Article Page: 22-26 Isolation of antibiotic producing Actinomycetes from soil

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin

More information

Studies on Antibiotic Synergism Against Enterococci

Studies on Antibiotic Synergism Against Enterococci Studies on Antibiotic Synergism Against Enterococci II. EFFECT OF VARIOUS ANTIBIOTICS ON THE UPTAKE OF 4C-LABELED STREPTOMYCIN BY ENTEROCOCCI ROBERT C. MOELLERING, JR. and ARNOLD N. WEINBERG From the Infectious

More information

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model AAC Accepts, published online ahead of print on 12 December 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.01109-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University.

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University. THE STABILITY OF E1VROFLOXA CIN A Senior Thesis By Meagan A. Dodge 1997-98 University Undergraduate Research Fellow Texas ASM University Group: Biology THE STABILITY OF ENROFLOXACIN MEAGANA, DODGE Submitted

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Y. Q. Xiong*, J. Caillon*, X. Y. Zhou*, G. Potel'*, D. Bugnon', P. Le Conte*, F. Le Gallon*, R. Le Floch', D. Baron* and H.

Y. Q. Xiong*, J. Caillon*, X. Y. Zhou*, G. Potel'*, D. Bugnon', P. Le Conte*, F. Le Gallon*, R. Le Floch', D. Baron* and H. Journal of Antimicrobial Chemotherapy (1995) 35, 697-706 Treatment of experimental rabbit infective endocarditis due to a raultidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and

More information

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants

More information

Other Beta - lactam Antibiotics

Other Beta - lactam Antibiotics Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics

More information

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities REVIEW Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities Fiona Walsh Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland

More information

Effeet on Bacterial Growth

Effeet on Bacterial Growth ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 17, p. 36-366 Copyright ( 17 American Society for Microbiology Vol., No. 5 Printed in U.S.A. Automatic Radiometric Measurement of Antibiotic Effeet on Bacterial

More information

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus B-O-021 Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus Nongluk Autarkool *a, Yothin Teethaisong a, Sajeera Kupittayanant b, Griangsak Eumkeb a

More information

Antimicrobial agents. are chemicals active against microorganisms

Antimicrobial agents. are chemicals active against microorganisms Antimicrobial agents are chemicals active against microorganisms Antibacterial Agents Are chemicals active against bacteria Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan

More information

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram

More information

In Vivo Efficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models

In Vivo Efficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2011, p. 1728 1733 Vol. 55, No. 4 0066-4804/11/$12.00 doi:10.1128/aac.00862-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. In Vivo

More information

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified)

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified) (Note: many chemicals have been used at one time or another to combat bacterial disease in koi. We have attempted

More information

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya 16 THE JOURNAL OF ANTIBIOTICS JAN. 1972 TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya Biological Research Laboratories, Research

More information

University, New York, New York Received for publication 7 May was measured by the broth dilution method as previously

University, New York, New York Received for publication 7 May was measured by the broth dilution method as previously ANTmIcaoBIAL AGuNTS AND CHUMTrHURAPY, Sept. 1976, p. 526-534 Copyright C 1976 American Society for Microbiology Vol. 10, No. 3 Printed in U.S.A. In Vitro Study of Netilmicin Compared with Other Aminoglycosides

More information

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1987, p. 546-550 0095-1137/87/030546-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 3 Evaluation of the AutoMicrobic System for Susceptibility

More information

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates Journal of Antimicrobial Chemotherapy Advance Access published February 8, 2007 Journal of Antimicrobial Chemotherapy doi:.93/jac/dkl52 In vitro pharmacodynamics of colistin against Acinetobacter baumannii

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.** Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,

More information

Antimicrobial Therapy

Antimicrobial Therapy Chapter 12 The Elements of Chemotherapy Topics - Antimicrobial Therapy - Selective Toxicity - Survey of Antimicrobial Drug - Microbial Drug Resistance - Drug and Host Interaction Antimicrobial Therapy

More information

ANTIBIOTICS IN PLASMA

ANTIBIOTICS IN PLASMA by LC/MS Code LC79010 (Daptomycin, Vancomycin, Streptomycin, Linezolid, Levofloxacin, Ciprofloxacin, Gentamicin, Amikacin, Teicoplanin) INTRODUCTION Technically it defines "antibiotic" a substance of natural

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA YONGYUTH JITTAROPAS NAOTO 1), RIKITOMI 2), and Kaizo MATSUMOTO 2) 1) Department of

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY* 44 DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY* AUTHOR: Cecilia C. Maramba-Lazarte, MD, MScID University of the Philippines College of Medicine-Philippine

More information